Exact Mass: 391.2444

Exact Mass Matches: 391.2444

Found 381 metabolites which its exact mass value is equals to given mass value 391.2444, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Heteratisine

Heteratisine

C22H33NO5 (391.2359)


Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid

   

NCIOpen2_009385

17-[(Benzylamino)methyl]estra-1,3,5(10)-triene-3,17beta-diol

C26H33NO2 (391.2511)


   

Diethylcarbamazine Citrate

Diethylcarbamazine Citrate

C16H29N3O8 (391.1955)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors

   

roquefortine D

roquefortine D

C22H25N5O2 (391.2008)


CONFIDENCE Penicillium bissettii

   

N-Stearoyltaurine

2-[(1-Oxooctadecyl)amino]ethanesulfonic acid

C20H41NO4S (391.2756)


N-Stearoyltaurine, also known as N-octadecanoyltaurine, belongs to the class of organic compounds known as N-acyl amines. N-Acyl amines are compounds containing a fatty acid moiety linked to an amine group through an ester linkage. Thus, N-stearoyltaurine is considered to be a fatty amide lipid molecule. N-Stearoyltaurine is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Specifically, N-stearoyltaurine belongs to the N-acyl taurines (NATs) fatty acid amide class. NATs with chains ranging in length from C16 to C24 have been identified in mice brain, liver, and kidney tissues. NATs were found to be regulated by the integral membrane enzyme fatty acid amide hydrolase (FAAH) and activated calcium channels from the transient receptor potential (TRP) family such as TRPV1 and TRPV4 (PMID: 16866345).

   

N-Arachidonoyl Serine

3-hydroxy-2-(icosa-5,8,11,14-tetraenamido)propanoic acid

C23H37NO4 (391.2722)


N-arachidonoyl serine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Serine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Serine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Serine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Myristoyl Tyrosine

3-(4-hydroxyphenyl)-2-tetradecanamidopropanoic acid

C23H37NO4 (391.2722)


N-myristoyl tyrosine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Tyrosine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Tyrosine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Tyrosine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide

N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenimidate

C26H33NO2 (391.2511)


   

17-(3-Pyridyl)-5,16-androstadien-3beta-acetate

17-(3-Pyridyl)-5,16-androstadien-3beta-acetic acid

C26H33NO2 (391.2511)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors D000970 - Antineoplastic Agents

   

3-O-Demethylfortimicin A

2-amino-N-(4-amino-3-{[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2,5,6-trihydroxycyclohexyl)-N-methylacetamide

C16H33N5O6 (391.2431)


   

Daporinad

N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-(pyridin-3-yl)prop-2-enamide

C24H29N3O2 (391.226)


   

Biriperone

1-(4-fluorophenyl)-4-{3,6,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,16}]heptadeca-1(10),11,13,15-tetraen-6-yl}butan-1-one

C24H26FN3O (391.206)


   

1-[4-[2-[2-(4-Fluorophenyl)ethoxy]ethoxy]phenoxy]-3-(propan-2-ylamino)propan-2-ol

1-(4-{2-[2-(4-fluorophenyl)ethoxy]ethoxy}phenoxy)-3-[(propan-2-yl)amino]propan-2-ol

C22H30FNO4 (391.2159)


   

3-((4-(2-Methoxyphenyl)piperazin-1-yl)methyl)-2,3-dihydroimidazo(1,2-c)quinazolin-5(6H)-one

3-((4-(2-Methoxyphenyl)piperazin-1-yl)methyl)-2,3-dihydroimidazo(1,2-c)quinazolin-5(6H)-one

C22H25N5O2 (391.2008)


   

2-[(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]acetic acid

2-[(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]acetic acid

C26H33NO2 (391.2511)


   

sphingosine phosphate

3-amino-4-hydroxy-3-(1-hydroxyhexadec-2-en-1-yl)-2,5,6-trioxa-1lambda5-phosphabicyclo[2.1.1]hexan-1-one

C18H34NO6P (391.2124)


   

3-[2-(1,1-dimethyl-allyl)-5-(3-methyl-but-2-enyl)-indol-3-ylmethylene]-6-methyl-piperazine-2,5-dione|Isoechulin A

3-[2-(1,1-dimethyl-allyl)-5-(3-methyl-but-2-enyl)-indol-3-ylmethylene]-6-methyl-piperazine-2,5-dione|Isoechulin A

C24H29N3O2 (391.226)


   
   

Methylcyclodecylprodiginine

Methylcyclodecylprodiginine

C25H33N3O (391.2623)


   

3-[2-(1,1-dimethyl-allyl)-6-(3-methyl-but-2-enyl)-indol-3-ylmethylene]-6-methyl-piperazine-2,5-dione|Cycloalanyl-2alpha,alpha-dimethylallyl-6gamma,gamma-dimethylallyldehydrotryptophyl

3-[2-(1,1-dimethyl-allyl)-6-(3-methyl-but-2-enyl)-indol-3-ylmethylene]-6-methyl-piperazine-2,5-dione|Cycloalanyl-2alpha,alpha-dimethylallyl-6gamma,gamma-dimethylallyldehydrotryptophyl

C24H29N3O2 (391.226)


   

Metacycloprodigiosin

Metacycloprodigiosin

C25H33N3O (391.2623)


   
   

Sachaconitine

Sachaconitine

C23H37NO4 (391.2722)


   

N-Methyl-7-epi-dioncophylline A

N-Methyl-7-epi-dioncophylline A

C25H29NO3 (391.2147)


   

Parvistemonine

Parvistemonine

C22H33NO5 (391.2359)


   

Streptorubin B

Butyl-meta-cycloheptylprodiginine

C25H33N3O (391.2623)


   

O-Methyltriphyophylline

O-Methyltriphyophylline

C25H29NO3 (391.2147)


   

N-Oxytuberostemonine

N-Oxytuberostemonine

C22H33NO5 (391.2359)


   

AGN-PC-0LPA90

AGN-PC-0LPA90

C22H33NO5 (391.2359)


   

N-Methyldioncophylline A

N-Methyldioncophylline A

C25H29NO3 (391.2147)


   

N-Methyltriphyophylline

N-Methyltriphyophylline

C25H29NO3 (391.2147)


   
   

N-Stearoyl Taurine

N-octadecanoyl-taurine

C20H41NO4S (391.2756)


   
   

daphnoldine B|methyl (8aRS,9RS,10aRS,11RS)-2,3,4,5,6,7,8,8a,9,10-decahydro-11-(hydroxymethyl)-11-(3-hydroxypentyl)-2-methyl-1H-4,10a-methanopentaleno[1,6-cd]azonine-9-carboxylate

daphnoldine B|methyl (8aRS,9RS,10aRS,11RS)-2,3,4,5,6,7,8,8a,9,10-decahydro-11-(hydroxymethyl)-11-(3-hydroxypentyl)-2-methyl-1H-4,10a-methanopentaleno[1,6-cd]azonine-9-carboxylate

C23H37NO4 (391.2722)


   

(17R,E)-2-hydroxy-4,6-dimethoxy-17-acetoxy-cyclopentadeca-1,3-diene[1,2-b]pyridine|patungensin

(17R,E)-2-hydroxy-4,6-dimethoxy-17-acetoxy-cyclopentadeca-1,3-diene[1,2-b]pyridine|patungensin

C22H33NO5 (391.2359)


   

karasamine

karasamine

C23H37NO4 (391.2722)


Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid

   
   
   
   

3-O-Demethylfortimicin A

3-O-Demethylfortimicin A

C16H33N5O6 (391.2431)


   

pengshenine B

pengshenine B

C22H33NO5 (391.2359)


   

isoipanguline A

isoipanguline A

C21H29NO6 (391.1995)


   
   
   
   

Butylcyclohexylprodigiosin

Butylcyclohexylprodigiosin

C25H33N3O (391.2623)


   

(7E,9aS,11S,13S,13aS)-4-formyl-2,3,4,5,6,8,9,9a,10,11,12,13-dodecahydro-11-methyl-8-oxo-1H-indeno[1,7a-c]azonine-11,13-diyl diacetate|N-formyllycoposerramine-T

(7E,9aS,11S,13S,13aS)-4-formyl-2,3,4,5,6,8,9,9a,10,11,12,13-dodecahydro-11-methyl-8-oxo-1H-indeno[1,7a-c]azonine-11,13-diyl diacetate|N-formyllycoposerramine-T

C21H29NO6 (391.1995)


   

NCGC00380319-01

NCGC00380319-01

C22H33NO5 (391.2359)


   

oxotuberostemonine A

oxotuberostemonine A

C22H33NO5 (391.2359)


   

stemona-amine C trifluoroacetate

stemona-amine C trifluoroacetate

C22H33NO5 (391.2359)


   
   

SCHEMBL18307152

SCHEMBL18307152

C21H29NO6 (391.1995)


   

N-Methyldioncophyllin a

N-Methyldioncophyllin a

C25H29NO3 (391.2147)


   

Ethylcyclononylprodigiosin

Ethylcyclononylprodigiosin

C25H33N3O (391.2623)


   
   

8-butyl-10-[(Z)-[(5Z)-3-methoxy-5-pyrrol-2-ylidenepyrrol-2-ylidene]methyl]-11-azabicyclo[7.2.1]dodeca-1(12),9-diene

8-butyl-10-[(Z)-[(5Z)-3-methoxy-5-pyrrol-2-ylidenepyrrol-2-ylidene]methyl]-11-azabicyclo[7.2.1]dodeca-1(12),9-diene

C25H33N3O (391.2623)


   

2-{4-[3-(4-hydroxy-3,5-dimethoxy-phenyl)-acryloyl]-piperazin-1-yl}-N-isopropyl-acetamide|N-Isopropyl-2-<4-(4-hydroxy-3,5-dimethoxycinnamoyl)-1-piperazinyl>-acetamid

2-{4-[3-(4-hydroxy-3,5-dimethoxy-phenyl)-acryloyl]-piperazin-1-yl}-N-isopropyl-acetamide|N-Isopropyl-2-<4-(4-hydroxy-3,5-dimethoxycinnamoyl)-1-piperazinyl>-acetamid

C20H29N3O5 (391.2107)


   
   
   
   
   
   
   
   
   
   

N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide

N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide

C26H33NO2 (391.2511)


   
   
   
   
   
   
   

o-Methyldioncophyllin a

o-Methyldioncophyllin a

C25H29NO3 (391.2147)


   

Rizatriptan benzoate

Rizatriptan Benzoate (Maxalt)

C22H25N5O2 (391.2008)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Rizatriptan benzoate (Maxalt) is a 5-HT1 agonist.

   

MLS001074102-01!

MLS001074102-01!

C16H29N3O8 (391.1955)


   

C22H33NO5_6,6,9a-Trimethyl-3-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-9-yl N-acetylvalinate

NCGC00380319-01_C22H33NO5_6,6,9a-Trimethyl-3-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-9-yl N-acetylvalinate

C22H33NO5 (391.2359)


   

C22H33NO5_D-Valine, N-acetyl-, (5aS,9S,9aS)-1,3,4,5,5a,6,7,8,9,9a-decahydro-6,6,9a-trimethyl-3-oxonaphtho[1,2-c]furan-9-yl ester

NCGC00180281-02_C22H33NO5_D-Valine, N-acetyl-, (5aS,9S,9aS)-1,3,4,5,5a,6,7,8,9,9a-decahydro-6,6,9a-trimethyl-3-oxonaphtho[1,2-c]furan-9-yl ester

C22H33NO5 (391.2359)


   

C22H25N5O2_3-(1H-Imidazol-4-ylmethyl)-10b-(2-methyl-3-buten-2-yl)-6,10b,11,11a-tetrahydro-2H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione

NCGC00180346-02_C22H25N5O2_3-(1H-Imidazol-4-ylmethyl)-10b-(2-methyl-3-buten-2-yl)-6,10b,11,11a-tetrahydro-2H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione

C22H25N5O2 (391.2008)


   

N-(3-hydroxytetradecanoyl)-L-phenylalanine

N-(3-hydroxytetradecanoyl)-L-phenylalanine

C23H37NO4 (391.2722)


   

Camellimidazole B

Camellimidazole B

C17H29N9O2 (391.2444)


   

Ala Lys Ser Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C15H29N5O7 (391.2067)


   

Ala Ser Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]hexanamido]-3-hydroxypropanoic acid

C15H29N5O7 (391.2067)


   

Ala Ser Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]hexanoic acid

C15H29N5O7 (391.2067)


   

Gly Lys Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C15H29N5O7 (391.2067)


   

Gly Lys Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C15H29N5O7 (391.2067)


   

Gly Ser Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]hexanamido]-3-hydroxybutanoic acid

C15H29N5O7 (391.2067)


   

Gly Ser Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-hydroxybutanamido]hexanoic acid

C15H29N5O7 (391.2067)


   

Gly Thr Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]hexanamido]-3-hydroxypropanoic acid

C15H29N5O7 (391.2067)


   

Gly Thr Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-hydroxypropanamido]hexanoic acid

C15H29N5O7 (391.2067)


   
   
   
   

Lys Ala Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C15H29N5O7 (391.2067)


   
   

Lys Gly Ser Thr

(2S,3R)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxypropanamido]-3-hydroxybutanoic acid

C15H29N5O7 (391.2067)


   

Lys Gly Thr Ser

(2S)-2-[(2S,3R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxybutanamido]-3-hydroxypropanoic acid

C15H29N5O7 (391.2067)


   
   
   
   

Lys Ser Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]propanamido]-3-hydroxypropanoic acid

C15H29N5O7 (391.2067)


   

Lys Ser Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]acetamido}-3-hydroxybutanoic acid

C15H29N5O7 (391.2067)


   

Lys Ser Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]propanoic acid

C15H29N5O7 (391.2067)


   

Lys Ser Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]acetic acid

C15H29N5O7 (391.2067)


   

Lys Thr Gly Ser

(2S)-2-{2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]acetamido}-3-hydroxypropanoic acid

C15H29N5O7 (391.2067)


   

Lys Thr Ser Gly

2-[(2S)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]acetic acid

C15H29N5O7 (391.2067)


   
   
   
   
   
   
   
   
   
   
   
   
   
   

Ser Ala Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]hexanamido]-3-hydroxypropanoic acid

C15H29N5O7 (391.2067)


   

Ser Ala Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-hydroxypropanamido]hexanoic acid

C15H29N5O7 (391.2067)


   
   

Ser Gly Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}hexanamido]-3-hydroxybutanoic acid

C15H29N5O7 (391.2067)


   

Ser Gly Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-hydroxybutanamido]hexanoic acid

C15H29N5O7 (391.2067)


   

Ser Lys Ala Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]propanamido]-3-hydroxypropanoic acid

C15H29N5O7 (391.2067)


   

Ser Lys Gly Thr

(2S,3R)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]acetamido}-3-hydroxybutanoic acid

C15H29N5O7 (391.2067)


   

Ser Lys Ser Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-hydroxypropanamido]propanoic acid

C15H29N5O7 (391.2067)


   

Ser Lys Thr Gly

2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-hydroxybutanamido]acetic acid

C15H29N5O7 (391.2067)


   

Ser Ser Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]propanamido]hexanoic acid

C15H29N5O7 (391.2067)


   

Ser Ser Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]hexanamido]propanoic acid

C15H29N5O7 (391.2067)


   

Ser Thr Gly Lys

(2S)-6-amino-2-{2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]acetamido}hexanoic acid

C15H29N5O7 (391.2067)


   

Ser Thr Lys Gly

2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]hexanamido]acetic acid

C15H29N5O7 (391.2067)


   

Thr Gly Lys Ser

(2S)-2-[(2S)-6-amino-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}hexanamido]-3-hydroxypropanoic acid

C15H29N5O7 (391.2067)


   

Thr Gly Ser Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-hydroxypropanamido]hexanoic acid

C15H29N5O7 (391.2067)


   

Thr Lys Gly Ser

(2S)-2-{2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]acetamido}-3-hydroxypropanoic acid

C15H29N5O7 (391.2067)


   

Thr Lys Ser Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]-3-hydroxypropanamido]acetic acid

C15H29N5O7 (391.2067)


   

Thr Ser Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]acetamido}hexanoic acid

C15H29N5O7 (391.2067)


   

Thr Ser Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]hexanamido]acetic acid

C15H29N5O7 (391.2067)


   

N-arachidonoyl D-serine

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-D-serine

C23H37NO4 (391.2722)


   

Fenretinide

4-Hydroxyphenylretinamide

C26H33NO2 (391.2511)


C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents

   

N-Arachidonoyl-L-Serine

N-[1-oxo-5Z,8Z,11Z,14Z-eicosatetraenyl]-L-serine

C23H37NO4 (391.2722)


An N-acyl-amino acid resulting from the formal condensation of the carboxy group of arachidonic acid with the amino group of L-serine. It is an endocannabinoid-like lipid isolated from bovine brains.

   

FK-866

N-[4-(1-benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2E-propenamide

C24H29N3O2 (391.226)


   

EMA-6

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-L-serine

C23H37NO4 (391.2722)


   

15-HETE-Ala

N-(15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-alanine

C23H37NO4 (391.2722)


   

12-HETE-Ala

N-(12S-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoyl)-alanine

C23H37NO4 (391.2722)


   

NA 23:5;O3

N-(12S-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoyl)-alanine

C23H37NO4 (391.2722)


   

NAT 18:0

N-octadecanoyl-taurine

C20H41NO4S (391.2756)


   

icas#6.1

(2S,3R,5R,6R)-5-hydroxy-6-(((2R,5R)-5-hydroxyhexan-2-yl)oxy)-2-methyltetrahydro-2H-pyran-3-yl-1H-indole-3-carboxylate

C21H29NO6 (391.1995)


   

icas#6.2

(2S,3R,5R,6R)-5-hydroxy-6-(((2S,5R)-5-hydroxyhexan-2-yl)oxy)-2-methyltetrahydro-2H-pyran-3-yl-1H-indole-3-carboxylate

C21H29NO6 (391.1995)


   
   
   

(S)-1-PHENYL-2-(P-TOLYL)ETHYLAMINE

(S)-1-PHENYL-2-(P-TOLYL)ETHYLAMINE

C24H29N3O2 (391.226)


   

1H-Benzimidazole,2-[1-[[1-(2-furanylmethyl)-1H-tetrazol-5-yl]methyl]-4-piperidinyl]-5,6-dimethyl-(9CI)

1H-Benzimidazole,2-[1-[[1-(2-furanylmethyl)-1H-tetrazol-5-yl]methyl]-4-piperidinyl]-5,6-dimethyl-(9CI)

C21H25N7O (391.212)


   

(+)-UH 232 maleate,cis-(+)-5-Methoxy-1-methyl-2-(di-N-propylamino)tetralinmaleate

(+)-UH 232 maleate,cis-(+)-5-Methoxy-1-methyl-2-(di-N-propylamino)tetralinmaleate

C22H33NO5 (391.2359)


   

1-(1-Boc-4-piperidyl)-3-methylpyrazole-4-boronic Acid Pinacol Ester

1-(1-Boc-4-piperidyl)-3-methylpyrazole-4-boronic Acid Pinacol Ester

C20H34BN3O4 (391.2642)


   

(R,R)-N-Benzyl-3,4-trans-(N-Boc)-diaminopyrrolidine

(R,R)-N-Benzyl-3,4-trans-(N-Boc)-diaminopyrrolidine

C21H33N3O4 (391.2471)


   

Binodenoson

Binodenoson

C17H25N7O4 (391.1968)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent Binodenoson (MRE-0470) is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1]. Binodenoson (MRE-0470) is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].

   

[4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

[4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

C19H30BNO5Si (391.1986)


   

1H-Indole-1-carboxylic acid, 2-borono-6-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, 1-(1,1-dimethylethyl) ester (9CI)

1H-Indole-1-carboxylic acid, 2-borono-6-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, 1-(1,1-dimethylethyl) ester (9CI)

C19H30BNO5Si (391.1986)


   

1H-Indole-1-carboxylic acid, 2-borono-5-[[[dimethyl(1-methylethyl)silyl]oxy]methyl]-, 1-(1,1-dimethylethyl) ester (9CI)

1H-Indole-1-carboxylic acid, 2-borono-5-[[[dimethyl(1-methylethyl)silyl]oxy]methyl]-, 1-(1,1-dimethylethyl) ester (9CI)

C19H30BNO5Si (391.1986)


   

Biriperone

CENTBUTINDOLE

C24H26FN3O (391.206)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

Octadecyltrimethylammonium bromide

Octadecyltrimethylammonium bromide

C21H46BrN (391.2813)


   

TETRA-N-BUTYLAMMONIUM TRIFLUOROMETHANESULFONATE

TETRA-N-BUTYLAMMONIUM TRIFLUOROMETHANESULFONATE

C17H36F3NO3S (391.2368)


   

2-Borono-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1H-indole-1-carboxylic acid 1-(1,1-dimethylethyl) ester

2-Borono-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1H-indole-1-carboxylic acid 1-(1,1-dimethylethyl) ester

C19H30BNO5Si (391.1986)


   
   

N-acetylphenylalanylarginine ethyl ester

N-acetylphenylalanylarginine ethyl ester

C19H29N5O4 (391.2219)


   

Cobalt(Ⅱ)bromate hexahydrate

Cobalt(Ⅱ)bromate hexahydrate

Co(BrO3)2•6H2O (391.2194)


   

Abiraterone acetate

Abiraterone acetate

C26H33NO2 (391.2511)


A sterol ester obtained by formal condensation of the 3-hydroxy group of abiraterone with the carboxy group of acetic acid. A prodrug that is converted in vivo to abiraterone. Used for treatment of metastatic castrate-resistant prostate cancer. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors C471 - Enzyme Inhibitor > C147923 - CYP17A1 Inhibitor D000970 - Antineoplastic Agents

   
   

N-(2-CYANO-ETHYL)-N-PYRIDIN-3-YLMETHYL-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE

N-(2-CYANO-ETHYL)-N-PYRIDIN-3-YLMETHYL-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE

C22H26BN3O3 (391.2067)


   

Daporinad

FK866 (APO866, Daporinad)

C24H29N3O2 (391.226)


C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor

   

Ethylhexyl methoxycrylene

Ethylhexyl methoxycrylene

C25H29NO3 (391.2147)


   

1-[4-[2-[2-(4-Fluorophenyl)ethoxy]ethoxy]phenoxy]-3-(propan-2-ylamino)propan-2-ol

1-[4-[2-[2-(4-Fluorophenyl)ethoxy]ethoxy]phenoxy]-3-(propan-2-ylamino)propan-2-ol

C22H30FNO4 (391.2159)


   

N^2^-[(2R)-2-{(1S)-1-[Formyl(hydroxy)amino]ethyl}-5-phenylpentanoyl]-N,3-dimethyl-L-valinamide

N^2^-[(2R)-2-{(1S)-1-[Formyl(hydroxy)amino]ethyl}-5-phenylpentanoyl]-N,3-dimethyl-L-valinamide

C21H33N3O4 (391.2471)


   

H-Leu-leu-phe-OH

H-Leu-leu-phe-OH

C21H33N3O4 (391.2471)


   

17-[(Benzylamino)methyl]estra-1,3,5(10)-triene-3,17beta-diol

17-[(Benzylamino)methyl]estra-1,3,5(10)-triene-3,17beta-diol

C26H33NO2 (391.2511)


   

tert-Butyl 4-((4-(1H-indol-4-yl)piperazin-1-yl)methyl)benzoate

tert-Butyl 4-((4-(1H-indol-4-yl)piperazin-1-yl)methyl)benzoate

C24H29N3O2 (391.226)


   

3-Cyclohexyl-D-Alanyl-N-(3-Chlorobenzyl)-L-Prolinamide

3-Cyclohexyl-D-Alanyl-N-(3-Chlorobenzyl)-L-Prolinamide

C21H30ClN3O2 (391.2026)


   

(3R,6S,6aS,8S,9R,10S,11aS,12S)-1-ethyl-8,10-dimethoxy-3-methyltetradecahydro-1H-3,6a,12-(epiethane[1,1,2]triyl)-7,9-methanonaphtho[2,3-b]azocine-6,11a-diol

(3R,6S,6aS,8S,9R,10S,11aS,12S)-1-ethyl-8,10-dimethoxy-3-methyltetradecahydro-1H-3,6a,12-(epiethane[1,1,2]triyl)-7,9-methanonaphtho[2,3-b]azocine-6,11a-diol

C23H37NO4 (391.2722)


   

3alpha,12alpha-Dihydroxy-5beta-cholanate

3alpha,12alpha-Dihydroxy-5beta-cholanate

C24H39O4- (391.2848)


   

3alpha,7beta-Dihydroxy-5beta-cholan-24-Oate

3alpha,7beta-Dihydroxy-5beta-cholan-24-Oate

C24H39O4- (391.2848)


   

Chenodeoxycholate anion

Chenodeoxycholate anion

C24H39O4- (391.2848)


   

Hyodeoxycholate

Hyodeoxycholate

C24H39O4- (391.2848)


A bile acid anion that is the conjugate base of hyodeoxycholic acid.

   

Murideoxycholate

Murideoxycholate

C24H39O4- (391.2848)


A bile acid anion that is the conjugate base of murideoxycholic acid.

   

3beta,12alpha-Dihydroxy-5beta-cholan-24-oate

3beta,12alpha-Dihydroxy-5beta-cholan-24-oate

C24H39O4- (391.2848)


A bile acid anion that is the conjugate base of 3beta,12alpha-dihydroxy-5beta-cholan-24-oic acid, obtained by deprotonation of the carboxy group. The 3beta-hydroxy epimer of deoxycholate. It is the major microspecies at pH 7.3.

   

3beta,7alpha-Dihydroxy-5beta-cholan-24-oate

3beta,7alpha-Dihydroxy-5beta-cholan-24-oate

C24H39O4- (391.2848)


A bile acid anion that is the conjugate base of 3beta,7alpha-dihydroxy-5beta-cholan-24-oic acid, obtained by deprotonation of the carboxy group. The 3beta-hydroxy epimer of chenodeoxycholate. It is the major microspecies at pH 7.3.

   

(6S)-5-[3-Methoxy-5-(1H-pyrrole-2-yl)-2H-pyrrole-2-ylidenemethyl]-6-butyl-2,4-heptano-1H-pyrrole

(6S)-5-[3-Methoxy-5-(1H-pyrrole-2-yl)-2H-pyrrole-2-ylidenemethyl]-6-butyl-2,4-heptano-1H-pyrrole

C25H33N3O (391.2623)


   

(R)-2-Ethyl-13-[[3-methoxy-5-(1H-pyrrol-2-yl)-2H-pyrrol-2-ylidene]methyl]-12-azabicyclo[9.2.1]tetradeca-11(14),13(1)-diene

(R)-2-Ethyl-13-[[3-methoxy-5-(1H-pyrrol-2-yl)-2H-pyrrol-2-ylidene]methyl]-12-azabicyclo[9.2.1]tetradeca-11(14),13(1)-diene

C25H33N3O (391.2623)


   

20-Hydroxy-prefusarin (open ring form)

20-Hydroxy-prefusarin (open ring form)

C22H33NO5 (391.2359)


   

(E)-3beta,14beta,21-trihydroxy-23-nor-5-beta-chol-20(22)-enate

(E)-3beta,14beta,21-trihydroxy-23-nor-5-beta-chol-20(22)-enate

C23H35O5- (391.2484)


   

3-amino-3-[(E)-1-hydroxyhexadec-2-enyl]-1-oxo-2,5,6-trioxa-1lambda5-phosphabicyclo[2.1.1]hexan-4-ol

3-amino-3-[(E)-1-hydroxyhexadec-2-enyl]-1-oxo-2,5,6-trioxa-1lambda5-phosphabicyclo[2.1.1]hexan-4-ol

C18H34NO6P (391.2124)


   

N-Arachidonoyl Serine

N-Arachidonoyl Serine

C23H37NO4 (391.2722)


   

Isoursodeoxycholate

Isoursodeoxycholate

C24H39O4- (391.2848)


A steroid acid anion that is the conjugate base of isoursodeoxycholic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Leu-Pro-Tyr

Leu-Pro-Tyr

C20H29N3O5 (391.2107)


A tripeptide composed of L-leucine, L-proline and L-tyrosine joined in sequence by peptide linkages.

   
   
   

3alpha,12alpha-Dihydroxy-5alpha-cholan-24-oate

3alpha,12alpha-Dihydroxy-5alpha-cholan-24-oate

C24H39O4- (391.2848)


   

1-Ethyl-2-methyl-N-[(E)-(4-morpholin-4-ylphenyl)methylideneamino]benzimidazole-5-carboxamide

1-Ethyl-2-methyl-N-[(E)-(4-morpholin-4-ylphenyl)methylideneamino]benzimidazole-5-carboxamide

C22H25N5O2 (391.2008)


   

7S,14S-diHpDHA(1-)

7S,14S-diHpDHA(1-)

C22H31O6- (391.2121)


   

(4Z,7Z,11Z,13Z,15E,17S,19Z)-10,17-bis(hydroperoxy)docosa-4,7,11,13,15,19-hexaenoate

(4Z,7Z,11Z,13Z,15E,17S,19Z)-10,17-bis(hydroperoxy)docosa-4,7,11,13,15,19-hexaenoate

C22H31O6- (391.2121)


   

7(S),17(S)-dihydroperoxydocosahexaenoate

7(S),17(S)-dihydroperoxydocosahexaenoate

C22H31O6- (391.2121)


   

1-Hexadecanoyl-sn-glycero-2,3-cyclic phosphate

1-Hexadecanoyl-sn-glycero-2,3-cyclic phosphate

C19H36O6P- (391.2249)


   
   
   
   
   
   
   
   
   
   
   

1-(3-Carboxypropyl)-9-(dimethylamino)-11,11-dimethyl-2,3,4,11-tetrahydronaphtho[2,3-g]quinolinium

1-(3-Carboxypropyl)-9-(dimethylamino)-11,11-dimethyl-2,3,4,11-tetrahydronaphtho[2,3-g]quinolinium

C25H31N2O2+ (391.2385)


   

(2S,3S,4R)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

(2S,3S,4R)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

C21H33N3O4 (391.2471)


   

N-cyclobutyl-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)carbamoylamino]oxan-2-yl]acetamide

N-cyclobutyl-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)carbamoylamino]oxan-2-yl]acetamide

C20H29N3O5 (391.2107)


   

N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

C20H29N3O5 (391.2107)


   

2-[(2S,3R,6S)-3-[[2-(dimethylamino)acetyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

2-[(2S,3R,6S)-3-[[2-(dimethylamino)acetyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

C20H29N3O5 (391.2107)


   

N-cyclobutyl-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)carbamoylamino]oxan-2-yl]acetamide

N-cyclobutyl-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)carbamoylamino]oxan-2-yl]acetamide

C20H29N3O5 (391.2107)


   

N-cyclobutyl-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide

N-cyclobutyl-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide

C20H29N3O5 (391.2107)


   

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2471)


   

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2471)


   

2-[(2R,3S,6R)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

2-[(2R,3S,6R)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

C20H29N3O5 (391.2107)


   

2-[(2R,3R,6R)-3-[[2-(dimethylamino)acetyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

2-[(2R,3R,6R)-3-[[2-(dimethylamino)acetyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

C20H29N3O5 (391.2107)


   

N-cyclobutyl-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide

N-cyclobutyl-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide

C20H29N3O5 (391.2107)


   

N-cyclobutyl-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide

N-cyclobutyl-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide

C20H29N3O5 (391.2107)


   

N-cyclobutyl-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide

N-cyclobutyl-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide

C20H29N3O5 (391.2107)


   

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2471)


   

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2471)


   

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2471)


   

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2471)


   

2-[(2S,3R,6R)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

2-[(2S,3R,6R)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

C20H29N3O5 (391.2107)


   

2-[(2S,3S,6S)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

2-[(2S,3S,6S)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

C20H29N3O5 (391.2107)


   

N-cyclobutyl-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide

N-cyclobutyl-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide

C20H29N3O5 (391.2107)


   

N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

C20H29N3O5 (391.2107)


   

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

C20H29N3O5 (391.2107)


   

N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

C20H29N3O5 (391.2107)


   

2-[(1S,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

2-[(1S,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C20H29N3O5 (391.2107)


   

2-[(1S,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

2-[(1S,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C20H29N3O5 (391.2107)


   

N-[[(2S,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-(3-pyridinylmethyl)-2-azetidinyl]methyl]acetamide

N-[[(2S,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-(3-pyridinylmethyl)-2-azetidinyl]methyl]acetamide

C24H29N3O2 (391.226)


   

N-[[(2S,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethyl-3-pyridinecarboxamide

N-[[(2S,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethyl-3-pyridinecarboxamide

C24H29N3O2 (391.226)


   

(2S,3R,4S)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

(2S,3R,4S)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

C21H33N3O4 (391.2471)


   

N-[[(2S,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethyl-4-pyridinecarboxamide

N-[[(2S,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethyl-4-pyridinecarboxamide

C24H29N3O2 (391.226)


   

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(3-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-propylacetamide

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(3-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-propylacetamide

C20H29N3O5 (391.2107)


   

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(2-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-propylacetamide

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(2-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-propylacetamide

C20H29N3O5 (391.2107)


   

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2471)


   

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2471)


   

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2471)


   

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2471)


   

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2471)


   

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2471)


   

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2471)


   

2-[(2R,3S,6S)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

2-[(2R,3S,6S)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

C20H29N3O5 (391.2107)


   

2-[(2S,3S,6R)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

2-[(2S,3S,6R)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

C20H29N3O5 (391.2107)


   

2-[(2R,3R,6S)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

2-[(2R,3R,6S)-3-[[2-(dimethylamino)-1-oxoethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(2-methoxyphenyl)methyl]acetamide

C20H29N3O5 (391.2107)


   

N-cyclobutyl-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide

N-cyclobutyl-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide

C20H29N3O5 (391.2107)


   

N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

C20H29N3O5 (391.2107)


   

N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

C20H29N3O5 (391.2107)


   

N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

C20H29N3O5 (391.2107)


   

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[[4-oxanyl(oxo)methyl]amino]ethyl]-3-oxanyl]-4-pyridinecarboxamide

C20H29N3O5 (391.2107)


   

2-[(1R,3R,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

2-[(1R,3R,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C20H29N3O5 (391.2107)


   

2-[(1R,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

2-[(1R,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C20H29N3O5 (391.2107)


   

2-[(1S,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

2-[(1S,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C20H29N3O5 (391.2107)


   

2-[(1R,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

2-[(1R,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C20H29N3O5 (391.2107)


   

2-[(1R,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

2-[(1R,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C20H29N3O5 (391.2107)


   

N-[[(2R,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-(3-pyridinylmethyl)-2-azetidinyl]methyl]acetamide

N-[[(2R,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-(3-pyridinylmethyl)-2-azetidinyl]methyl]acetamide

C24H29N3O2 (391.226)


   

N-[[(2R,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethyl-3-pyridinecarboxamide

N-[[(2R,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethyl-3-pyridinecarboxamide

C24H29N3O2 (391.226)


   

N-[[(2S,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethyl-3-pyridinecarboxamide

N-[[(2S,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethyl-3-pyridinecarboxamide

C24H29N3O2 (391.226)


   

(2R,3R,4S)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

(2R,3R,4S)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

C21H33N3O4 (391.2471)


   

(2R,3S,4R)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

(2R,3S,4R)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

C21H33N3O4 (391.2471)


   

N-[[(2R,3S,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethyl-4-pyridinecarboxamide

N-[[(2R,3S,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-ethyl-4-pyridinecarboxamide

C24H29N3O2 (391.226)


   

[(1R)-7-methoxy-1-(phenylmethyl)-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol

[(1R)-7-methoxy-1-(phenylmethyl)-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C24H29N3O2 (391.226)


   
   

(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid

(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid

C21H33N3O4 (391.2471)


   
   
   
   
   
   
   
   
   
   
   
   

2-[Hydroxy(2-naphthyl)methyl]-N-(3-methoxyphenyl)-N-methylhexanamide

2-[Hydroxy(2-naphthyl)methyl]-N-(3-methoxyphenyl)-N-methylhexanamide

C25H29NO3 (391.2147)


   

(3S,6E)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-7-(3-methylbut-2-enyl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione

(3S,6E)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-7-(3-methylbut-2-enyl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione

C24H29N3O2 (391.226)


   

(3S,6E)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-5-(3-methylbut-2-enyl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione

(3S,6E)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-5-(3-methylbut-2-enyl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione

C24H29N3O2 (391.226)


   

1-Methyl-5-[2-[methyl(1-phenylpropan-2-yl)amino]ethyl]-2-phenyl-4-propan-2-ylpyrazol-3-one

1-Methyl-5-[2-[methyl(1-phenylpropan-2-yl)amino]ethyl]-2-phenyl-4-propan-2-ylpyrazol-3-one

C25H33N3O (391.2623)


   

(1S,2S,6S,9S,11R,14R,17S,18S,19S)-12-ethyl-9,19-dihydroxy-17-methoxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.12,6.01,11.03,9.014,18]icosan-4-one

(1S,2S,6S,9S,11R,14R,17S,18S,19S)-12-ethyl-9,19-dihydroxy-17-methoxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.12,6.01,11.03,9.014,18]icosan-4-one

C22H33NO5 (391.2359)


   

(1S,2S,6S,9S,11R,14R,17S,19S)-12-ethyl-9,19-dihydroxy-17-methoxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.12,6.01,11.03,9.014,18]icosan-4-one

(1S,2S,6S,9S,11R,14R,17S,19S)-12-ethyl-9,19-dihydroxy-17-methoxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.12,6.01,11.03,9.014,18]icosan-4-one

C22H33NO5 (391.2359)


   
   

HexCer 8:1;2O/4:0

HexCer 8:1;2O/4:0

C18H33NO8 (391.2206)


   

HexCer 9:1;2O/3:0

HexCer 9:1;2O/3:0

C18H33NO8 (391.2206)


   

HexCer 10:1;2O/2:0

HexCer 10:1;2O/2:0

C18H33NO8 (391.2206)


   

N-Acetylvalylphenylalanylalanine methyl ester

N-Acetylvalylphenylalanylalanine methyl ester

C20H29N3O5 (391.2107)


   

N-Stearoyltaurine

N-Stearoyltaurine

C20H41NO4S (391.2756)


A fatty acid-taurine conjugate derived from stearic acid.

   

deoxycholate

deoxycholate

C24H39O4 (391.2848)


   

ursodeoxycholate

ursodeoxycholate

C24H39O4 (391.2848)


A bile acid anion that is the conjugate base of ursodeoxycholic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Allodeoxycholate

Allodeoxycholate

C24H39O4 (391.2848)


A bile acid anion that is the conjugate base of allodeoxycholic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(4Z,7Z,11Z,13Z,15E,17S,19Z)-10,17-bis(hydroperoxy)docosahexaenoate

(4Z,7Z,11Z,13Z,15E,17S,19Z)-10,17-bis(hydroperoxy)docosahexaenoate

C22H31O6 (391.2121)


A docosanoid anion that is the conjugate base of (4Z,7Z,11Z,13Z,15E,17S,19Z)-10,17-bis(hydroperoxy)docosahexaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(7S,17S)-bis(hydroperoxy)-(4Z,8E,10Z,13Z,15E,19Z)-docosahexaenoate

(7S,17S)-bis(hydroperoxy)-(4Z,8E,10Z,13Z,15E,19Z)-docosahexaenoate

C22H31O6 (391.2121)


A docosanoid anion that is the conjugate base of (7S,17S)-bis(hydroperoxy)-(4Z,8E,10Z,13Z,15E,19Z)-docosahexaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

ATTO 610-2(1+)

ATTO 610-2(1+)

C25H31N2O2 (391.2385)


The cationic form of a fluorescent dye derived from a tetrahydronaphtho[2,3-g]quinoline.

   

Chenodeoxycholate

Chenodeoxycholate

C24H39O4 (391.2848)


Conjugate base of chenodeoxycholic acid; major species at pH 7.3.

   

SPHP(20:1)

SPHP(m20:1)

C20H42NO4P (391.2851)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-Asp 18:4(6Z,9Z,12Z,15Z)

NA-Asp 18:4(6Z,9Z,12Z,15Z)

C22H33NO5 (391.2359)


   

NA-His 16:1(9Z)

NA-His 16:1(9Z)

C22H37N3O3 (391.2835)


   

NA-Ser 20:4(5Z,8Z,11Z,14Z)

NA-Ser 20:4(5Z,8Z,11Z,14Z)

C23H37NO4 (391.2722)


   

NA-Taurine 18:0

NA-Taurine 18:0

C20H41NO4S (391.2756)


   
   
   
   

ST 19:3;O4;Gly

ST 19:3;O4;Gly

C21H29NO6 (391.1995)


   

ST 20:2;O3;Gly

ST 20:2;O3;Gly

C22H33NO5 (391.2359)


   

ST 21:1;O2;Gly

ST 21:1;O2;Gly

C23H37NO4 (391.2722)


   

(1s,2r,3r,4s,5r,8s,9s,16s,17r)-11-ethyl-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,16-diol

(1s,2r,3r,4s,5r,8s,9s,16s,17r)-11-ethyl-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,16-diol

C23H37NO4 (391.2722)


   

(17r)-2-hydroxy-4,6-dimethoxy-7h,8h,9h,10h,11h,12h,13h,14h,15h,16h,17h-cyclopentadeca[b]pyridin-17-yl acetate

(17r)-2-hydroxy-4,6-dimethoxy-7h,8h,9h,10h,11h,12h,13h,14h,15h,16h,17h-cyclopentadeca[b]pyridin-17-yl acetate

C22H33NO5 (391.2359)


   

(1s,2r,3r,4s,5s,6s,8s,9s,10r,13s,16s,17r)-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-ene-4,8-diol

(1s,2r,3r,4s,5s,6s,8s,9s,10r,13s,16s,17r)-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-ene-4,8-diol

C22H33NO5 (391.2359)


   

5-hydroxy-6-methyl-3-{[7-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1,6-dihydropyrazin-2-one

5-hydroxy-6-methyl-3-{[7-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1,6-dihydropyrazin-2-one

C24H29N3O2 (391.226)


   

n-(2-{4-[(3,7-dimethyl-5-oxoocta-3,6-dien-1-yl)oxy]phenyl}ethyl)benzenecarboximidic acid

n-(2-{4-[(3,7-dimethyl-5-oxoocta-3,6-dien-1-yl)oxy]phenyl}ethyl)benzenecarboximidic acid

C25H29NO3 (391.2147)


   

(1r,3r)-7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-8-ol

(1r,3r)-7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-8-ol

C25H29NO3 (391.2147)


   

(1s,2r,3s,6r,9s,10r,11r,14r,17s,18r,19s)-12-ethyl-9,19-dihydroxy-17-methoxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.1²,⁶.0¹,¹¹.0³,⁹.0¹⁴,¹⁸]icosan-4-one

(1s,2r,3s,6r,9s,10r,11r,14r,17s,18r,19s)-12-ethyl-9,19-dihydroxy-17-methoxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.1²,⁶.0¹,¹¹.0³,⁹.0¹⁴,¹⁸]icosan-4-one

C22H33NO5 (391.2359)


   

8-ethyl-13,15-dimethoxy-5-oxa-8-azaheptacyclo[8.7.2.1¹⁴,¹⁷.0¹,⁹.0⁴,⁶.0⁶,¹⁸.0¹¹,¹⁶]icosane-2,11-diol

8-ethyl-13,15-dimethoxy-5-oxa-8-azaheptacyclo[8.7.2.1¹⁴,¹⁷.0¹,⁹.0⁴,⁶.0⁶,¹⁸.0¹¹,¹⁶]icosane-2,11-diol

C22H33NO5 (391.2359)


   

(3r)-3-hydroxy-2-({hydroxy[(2s,3s)-3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-yl]methylidene}amino)butanoic acid

(3r)-3-hydroxy-2-({hydroxy[(2s,3s)-3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-yl]methylidene}amino)butanoic acid

C21H29NO6 (391.1995)


   

(2r)-2-ethyl-13-{[(5e)-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

(2r)-2-ethyl-13-{[(5e)-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

C25H33N3O (391.2623)


   

(2s)-2-ethyl-13-{[(5e)-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

(2s)-2-ethyl-13-{[(5e)-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

C25H33N3O (391.2623)


   

2-ethyl-13-{[(5z)-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

2-ethyl-13-{[(5z)-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

C25H33N3O (391.2623)


   

(3s,6z)-3-methyl-6-{[5-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

(3s,6z)-3-methyl-6-{[5-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

C24H29N3O2 (391.226)


   

5-hydroxy-6-methyl-3-{[5-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1,6-dihydropyrazin-2-one

5-hydroxy-6-methyl-3-{[5-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1,6-dihydropyrazin-2-one

C24H29N3O2 (391.226)


   

(1s,2s,3s,4r,5r,6r,8r,9s,10r,13r,16s,17r)-11-ethyl-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol

(1s,2s,3s,4r,5r,6r,8r,9s,10r,13r,16s,17r)-11-ethyl-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol

C23H37NO4 (391.2722)


   

(2s,3r)-3-hydroxy-2-({hydroxy[(2s,3s)-3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-yl]methylidene}amino)butanoic acid

(2s,3r)-3-hydroxy-2-({hydroxy[(2s,3s)-3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-yl]methylidene}amino)butanoic acid

C21H29NO6 (391.1995)


   

(2s)-2-ethyl-13-{[(5z)-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

(2s)-2-ethyl-13-{[(5z)-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

C25H33N3O (391.2623)


   

5-hydroxy-6-methyl-3-{[6-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1,6-dihydropyrazin-2-one

5-hydroxy-6-methyl-3-{[6-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1,6-dihydropyrazin-2-one

C24H29N3O2 (391.226)


   

(e,5z)-5-({4-butyl-1h,4h,5h,6h,7h,8h,9h,10h-cyclonona[b]pyrrol-2-yl}methylidene)-4-methoxy-1h-2,2'-bipyrrolylidene

(e,5z)-5-({4-butyl-1h,4h,5h,6h,7h,8h,9h,10h-cyclonona[b]pyrrol-2-yl}methylidene)-4-methoxy-1h-2,2'-bipyrrolylidene

C25H33N3O (391.2623)


   

(1s,2s,4s,6s,9r,10s,11s,13r,14r,15s,16r,17r,18s)-8-ethyl-13,15-dimethoxy-5-oxa-8-azaheptacyclo[8.7.2.1¹⁴,¹⁷.0¹,⁹.0⁴,⁶.0⁶,¹⁸.0¹¹,¹⁶]icosane-2,11-diol

(1s,2s,4s,6s,9r,10s,11s,13r,14r,15s,16r,17r,18s)-8-ethyl-13,15-dimethoxy-5-oxa-8-azaheptacyclo[8.7.2.1¹⁴,¹⁷.0¹,⁹.0⁴,⁶.0⁶,¹⁸.0¹¹,¹⁶]icosane-2,11-diol

C22H33NO5 (391.2359)


   

(12r,13r,15r)-13-chloro-12-ethenyl-8,8,9,12,19,19-hexamethyl-6-azapentacyclo[13.3.1.0⁵,¹⁸.0⁷,¹⁷.0¹¹,¹⁶]nonadeca-1(18),2,4,7(17),9,11(16)-hexaene

(12r,13r,15r)-13-chloro-12-ethenyl-8,8,9,12,19,19-hexamethyl-6-azapentacyclo[13.3.1.0⁵,¹⁸.0⁷,¹⁷.0¹¹,¹⁶]nonadeca-1(18),2,4,7(17),9,11(16)-hexaene

C26H30ClN (391.2067)


   

(1s,2r,3r,5s,7r,10s,11r,13s,14s,16r,17r,18s,19s)-4-ethyl-16-methoxy-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-13,14,18-triol

(1s,2r,3r,5s,7r,10s,11r,13s,14s,16r,17r,18s,19s)-4-ethyl-16-methoxy-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-13,14,18-triol

C22H33NO5 (391.2359)


   

2-ethyl-13-({4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene}methyl)-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

2-ethyl-13-({4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene}methyl)-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

C25H33N3O (391.2623)


   

(1s,6s,9s,11r,14r,17s,19s)-12-ethyl-9,19-dihydroxy-17-methoxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.1²,⁶.0¹,¹¹.0³,⁹.0¹⁴,¹⁸]icosan-4-one

(1s,6s,9s,11r,14r,17s,19s)-12-ethyl-9,19-dihydroxy-17-methoxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.1²,⁶.0¹,¹¹.0³,⁹.0¹⁴,¹⁸]icosan-4-one

C22H33NO5 (391.2359)


   

4-methoxy-20-methyl-24,25,26-triazatetracyclo[19.2.1.1²,⁵.1⁷,¹⁰]hexacosa-1(23),2(26),3,5,7,9,21-heptaene

4-methoxy-20-methyl-24,25,26-triazatetracyclo[19.2.1.1²,⁵.1⁷,¹⁰]hexacosa-1(23),2(26),3,5,7,9,21-heptaene

C25H33N3O (391.2623)


   

2-hydroxy-4,6-dimethoxy-7h,8h,9h,10h,11h,12h,13h,14h,15h,16h,17h-cyclopentadeca[b]pyridin-17-yl acetate

2-hydroxy-4,6-dimethoxy-7h,8h,9h,10h,11h,12h,13h,14h,15h,16h,17h-cyclopentadeca[b]pyridin-17-yl acetate

C22H33NO5 (391.2359)


   

(1s,4s,8s,9e,11r,12s,14r,15s,16r,17s)-4,8,19-trihydroxy-15-methyl-17-(2-methylpropyl)-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-9,18-dien-2-one

(1s,4s,8s,9e,11r,12s,14r,15s,16r,17s)-4,8,19-trihydroxy-15-methyl-17-(2-methylpropyl)-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-9,18-dien-2-one

C22H33NO5 (391.2359)


   

(5z,20r)-4-methoxy-20-methyl-24,25,26-triazatetracyclo[19.2.1.1²,⁵.1⁷,¹⁰]hexacosa-1(23),2(26),3,5,7,9,21-heptaene

(5z,20r)-4-methoxy-20-methyl-24,25,26-triazatetracyclo[19.2.1.1²,⁵.1⁷,¹⁰]hexacosa-1(23),2(26),3,5,7,9,21-heptaene

C25H33N3O (391.2623)


   

(3s,6z)-3-methyl-6-{[7-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

(3s,6z)-3-methyl-6-{[7-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

C24H29N3O2 (391.226)


   

(1s,4r,7s,9r)-6-hydroxy-4-(3h-imidazol-4-ylmethyl)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1s,4r,7s,9r)-6-hydroxy-4-(3h-imidazol-4-ylmethyl)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C22H25N5O2 (391.2008)


   

(2r)-2-ethyl-13-{[(z,5z)-4-methoxy-1h-[2,2'-bipyrrolyliden]-5-ylidene]methyl}-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

(2r)-2-ethyl-13-{[(z,5z)-4-methoxy-1h-[2,2'-bipyrrolyliden]-5-ylidene]methyl}-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

C25H33N3O (391.2623)


   

4,8,19-trihydroxy-15-methyl-17-(2-methylpropyl)-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-9,18-dien-2-one

4,8,19-trihydroxy-15-methyl-17-(2-methylpropyl)-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-9,18-dien-2-one

C22H33NO5 (391.2359)


   

5-({4-butyl-1h,4h,5h,6h,7h,8h,9h,10h-cyclonona[b]pyrrol-2-yl}methylidene)-4-methoxy-1'h-2,2'-bipyrrole

5-({4-butyl-1h,4h,5h,6h,7h,8h,9h,10h-cyclonona[b]pyrrol-2-yl}methylidene)-4-methoxy-1'h-2,2'-bipyrrole

C25H33N3O (391.2623)


   

(2s,3r)-3-hydroxy-2-({hydroxy[(2r,3s)-3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-yl]methylidene}amino)butanoic acid

(2s,3r)-3-hydroxy-2-({hydroxy[(2r,3s)-3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-yl]methylidene}amino)butanoic acid

C21H29NO6 (391.1995)


   

7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-8-ol

7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-8-ol

C25H29NO3 (391.2147)


   

11-ethyl-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol

11-ethyl-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol

C23H37NO4 (391.2722)


   

2-butyl-11-{[(z,5z)-4-methoxy-1h-[2,2'-bipyrrolyliden]-5-ylidene]methyl}-10-azabicyclo[7.2.1]dodeca-1(11),9(12)-diene

2-butyl-11-{[(z,5z)-4-methoxy-1h-[2,2'-bipyrrolyliden]-5-ylidene]methyl}-10-azabicyclo[7.2.1]dodeca-1(11),9(12)-diene

C25H33N3O (391.2623)


   

(1s,3s)-7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-8-ol

(1s,3s)-7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-8-ol

C25H29NO3 (391.2147)


   

n-[(2s)-1-{[(5as,9s,9as,9br)-6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-9-yl]oxy}-3-methyl-1-oxobutan-2-yl]ethanimidic acid

n-[(2s)-1-{[(5as,9s,9as,9br)-6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-9-yl]oxy}-3-methyl-1-oxobutan-2-yl]ethanimidic acid

C22H33NO5 (391.2359)


   

(3s,6z)-3-methyl-6-{[6-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

(3s,6z)-3-methyl-6-{[6-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

C24H29N3O2 (391.226)


   

4-ethyl-16-methoxy-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-13,14,18-triol

4-ethyl-16-methoxy-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-13,14,18-triol

C22H33NO5 (391.2359)


   

12-ethyl-9,19-dihydroxy-17-methoxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.1²,⁶.0¹,¹¹.0³,⁹.0¹⁴,¹⁸]icosan-4-one

12-ethyl-9,19-dihydroxy-17-methoxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.1²,⁶.0¹,¹¹.0³,⁹.0¹⁴,¹⁸]icosan-4-one

C22H33NO5 (391.2359)


   

11-ethyl-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,16-diol

11-ethyl-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,16-diol

C23H37NO4 (391.2722)


   

n-[1-({6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-9-yl}oxy)-3-methyl-1-oxobutan-2-yl]ethanimidic acid

n-[1-({6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-9-yl}oxy)-3-methyl-1-oxobutan-2-yl]ethanimidic acid

C22H33NO5 (391.2359)


   

(3r,6z)-3-methyl-6-{[6-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

(3r,6z)-3-methyl-6-{[6-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

C24H29N3O2 (391.226)


   

(2s)-4-amino-n-(5-amino-4-{[3-amino-6-(aminomethyl)oxan-2-yl]oxy}-2,3-dihydroxycyclohexyl)-2-hydroxybutanimidic acid

(2s)-4-amino-n-(5-amino-4-{[3-amino-6-(aminomethyl)oxan-2-yl]oxy}-2,3-dihydroxycyclohexyl)-2-hydroxybutanimidic acid

C16H33N5O6 (391.2431)


   

(3r,6e)-3-methyl-6-{[6-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

(3r,6e)-3-methyl-6-{[6-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

C24H29N3O2 (391.226)


   

[(1r,7r,7ar)-7-[(2-phenylacetyl)oxy]-hexahydro-1h-pyrrolizin-1-yl]methyl (2s,3r)-2,3-dihydroxy-2-methylbutanoate

[(1r,7r,7ar)-7-[(2-phenylacetyl)oxy]-hexahydro-1h-pyrrolizin-1-yl]methyl (2s,3r)-2,3-dihydroxy-2-methylbutanoate

C21H29NO6 (391.1995)


   

(3r,5s)-5-[(3r,9r,9as)-9-[(2r,3r,3as,6s,6as)-2,6-dimethyl-5-oxo-tetrahydro-2h-furo[3,2-b]furan-3-yl]-octahydro-1h-pyrrolo[1,2-a]azepin-3-yl]-3-methyloxolan-2-one

(3r,5s)-5-[(3r,9r,9as)-9-[(2r,3r,3as,6s,6as)-2,6-dimethyl-5-oxo-tetrahydro-2h-furo[3,2-b]furan-3-yl]-octahydro-1h-pyrrolo[1,2-a]azepin-3-yl]-3-methyloxolan-2-one

C22H33NO5 (391.2359)


   

(1s,2r,3r,4s,5s,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol

(1s,2r,3r,4s,5s,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8-diol

C23H37NO4 (391.2722)


   

n-[2-(4-{[(3z)-3,7-dimethyl-5-oxoocta-3,6-dien-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

n-[2-(4-{[(3z)-3,7-dimethyl-5-oxoocta-3,6-dien-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

C25H29NO3 (391.2147)


   

(1s,2r,3r,4s,5r,6s,8s,9s,10r,13s,16s,17r)-11-ethyl-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,16-diol

(1s,2r,3r,4s,5r,6s,8s,9s,10r,13s,16s,17r)-11-ethyl-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,16-diol

C23H37NO4 (391.2722)


   

2-amino-n-[(1s,2r,3r,4s,5r,6s)-4-amino-3-{[(2r,3r,6r)-3-amino-6-(aminomethyl)oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl]-n-methylacetamide

2-amino-n-[(1s,2r,3r,4s,5r,6s)-4-amino-3-{[(2r,3r,6r)-3-amino-6-(aminomethyl)oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl]-n-methylacetamide

C16H33N5O6 (391.2431)


   

(9e)-4,8,19-trihydroxy-15-methyl-17-(2-methylpropyl)-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-9,18-dien-2-one

(9e)-4,8,19-trihydroxy-15-methyl-17-(2-methylpropyl)-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-9,18-dien-2-one

C22H33NO5 (391.2359)


   

(2s)-2-butyl-11-{[(z,5z)-4-methoxy-1h-[2,2'-bipyrrolyliden]-5-ylidene]methyl}-10-azabicyclo[7.2.1]dodeca-1(11),9(12)-diene

(2s)-2-butyl-11-{[(z,5z)-4-methoxy-1h-[2,2'-bipyrrolyliden]-5-ylidene]methyl}-10-azabicyclo[7.2.1]dodeca-1(11),9(12)-diene

C25H33N3O (391.2623)


   

(3s,5s)-5-[(3s,9r,9as)-9-[(2s,3r,3ar,6s,6ar)-2,6-dimethyl-5-oxo-tetrahydro-2h-furo[3,2-b]furan-3-yl]-octahydro-1h-pyrrolo[1,2-a]azepin-3-yl]-3-methyloxolan-2-one

(3s,5s)-5-[(3s,9r,9as)-9-[(2s,3r,3ar,6s,6ar)-2,6-dimethyl-5-oxo-tetrahydro-2h-furo[3,2-b]furan-3-yl]-octahydro-1h-pyrrolo[1,2-a]azepin-3-yl]-3-methyloxolan-2-one

C22H33NO5 (391.2359)


   

(1s,2s,4s,6s,9r,10s,11s,13s,14r,15s,16r,17r,18s)-8-ethyl-13,15-dimethoxy-5-oxa-8-azaheptacyclo[8.7.2.1¹⁴,¹⁷.0¹,⁹.0⁴,⁶.0⁶,¹⁸.0¹¹,¹⁶]icosane-2,11-diol

(1s,2s,4s,6s,9r,10s,11s,13s,14r,15s,16r,17r,18s)-8-ethyl-13,15-dimethoxy-5-oxa-8-azaheptacyclo[8.7.2.1¹⁴,¹⁷.0¹,⁹.0⁴,⁶.0⁶,¹⁸.0¹¹,¹⁶]icosane-2,11-diol

C22H33NO5 (391.2359)


   

{7-[(2-phenylacetyl)oxy]-hexahydro-1h-pyrrolizin-1-yl}methyl 2,3-dihydroxy-2-methylbutanoate

{7-[(2-phenylacetyl)oxy]-hexahydro-1h-pyrrolizin-1-yl}methyl 2,3-dihydroxy-2-methylbutanoate

C21H29NO6 (391.1995)


   

(2r)-2-butyl-11-{[(5e)-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}-10-azabicyclo[7.2.1]dodeca-1(11),9(12)-diene

(2r)-2-butyl-11-{[(5e)-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}-10-azabicyclo[7.2.1]dodeca-1(11),9(12)-diene

C25H33N3O (391.2623)


   

3-hydroxy-2-({hydroxy[3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-yl]methylidene}amino)butanoic acid

3-hydroxy-2-({hydroxy[3-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-yl]methylidene}amino)butanoic acid

C21H29NO6 (391.1995)


   

(1s,5r,6s,8s,9s,10r,13r,16s)-11-ethyl-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,16-diol

(1s,5r,6s,8s,9s,10r,13r,16s)-11-ethyl-4,6-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,16-diol

C23H37NO4 (391.2722)


   

6-hydroxy-4-(3h-imidazol-4-ylmethyl)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

6-hydroxy-4-(3h-imidazol-4-ylmethyl)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C22H25N5O2 (391.2008)


   

6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-ene-4,8-diol

6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-ene-4,8-diol

C22H33NO5 (391.2359)